Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net income	$ 6,254,000	$ 7,626,000
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for Credit Losses	821,000	1,525,000
Change in deferred loan origination costs/fees, net	(179,000)	(93,000)
Depreciation and amortization	448,000	386,000
Stock-based compensation expense	100,000	99,000
Loss on sale of investment securities	19,826,000	0
Amortization of investment security premiums	267,000	324,000
Accretion of investment security discounts	(264,000)	(201,000)
Loss on sale of other vehicles	15,000	0
Gain on sale of loans held for sale	0	(230,000)
Loans originated for sale	(251,000)	(736,000)
Proceeds from loan sales	0	4,627,000
Earnings on bank-owned life insurance	(96,000)	(104,000)
Gain on sale of buildings	(19,854,000)	0
Decrease in accrued interest receivable and other assets	1,151,000	1,445,000
Increase in accrued interest payable and other liabilities	924,000	170,000
Net cash provided by operating activities	9,162,000	14,838,000
Cash Flows from Investing Activities:
Proceeds from principal repayments from available-for-sale mortgage-backed securities	7,871,000	7,011,000
Proceeds from sale of investments	114,838,000	0
Proceeds from matured and called available-for-sale securities	850,000	1,135,000
Purchases of available-for-sale securities	(88,805,000)	(40,338,000)
Purchase of FRB stock	(3,000)	(2,000)
Net increase in loans	(18,227,000)	(5,494,000)
Proceeds from sale of other vehicles	310,000	139,000
Proceeds from bank owned life insurance	0	327,000
Proceeds from the sale of buildings	25,690,000	0
Purchase of premises and equipment	(191,000)	(956,000)
Net cash provided by (used in) investing activities	42,333,000	(38,178,000)
Cash Flows from Financing Activities:
Net decrease in demand, interest bearing and savings deposits	(32,990,000)	(50,888,000)
Net decrease in time deposits	(977,000)	(176,000)
Net decrease in securities sold under agreements to repurchase	(3,723,000)	(1,710,000)
Cash dividends paid on common stock	(1,588,000)	(1,463,000)
Redemption of Trust Preferred Securities	0	(10,310,000)
Increase in other borrowings	30,000,000	10,000,000
Proceeds from exercise of stock options	359,000	137,000
Net cash used in by financing activities	(8,919,000)	(54,410,000)
Increase (decrease) in cash and cash equivalents	42,576,000	(77,750,000)
Cash and Cash Equivalents at Beginning of Year	85,655,000	183,426,000
Cash and Cash Equivalents at End of Period	128,231,000	105,676,000
Supplemental Disclosure of Cash Flow Information:
Interest expense	2,569,000	632,000
Supplemental noncash disclosures
Real estate and vehicles acquired through foreclosure	220,000	303,000
Common stock retired in connection with the exercise of stock options	39,000	154,000
Lease liabilities arising from obtaining right-of-use assets	$ 22,588,000	$ 0